Wu, A. et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 27(3), 325–328 (2020).
Yanes-Lane, M. et al. Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis. PLoS ONE 15(11), e0241536 (2020).
Wu, Z. & McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323(13), 1239–1242 (2020).
Schurr, T. G. Host genetic factors and susceptibility to SARS-CoV-2 infection. Am. J. Hum. Biol. 32(5), e23497 (2020).
Kachuri, L. et al. The landscape of host genetic factors involved in immune response to common viral infections. MedRxiv Preprint Server Health Sci. https://doi.org/10.1101/2020.05.01.20088054 (2020).
Smatti, M. K., Al-Sarraj, Y. A., Albagha, O. & Yassine, H. M. Host genetic variants potentially associated with SARS-CoV-2: A multi-population analysis. Front. Genet. 11, 578523. https://doi.org/10.3389/fgene.2020.578523 (2020).
Kuo, C.-L. et al. APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort. J. Gerontol. Ser. A 75(11), 2231–2232 (2020).
Morton, A. M., Furtado, J. D., Mendivil, C. O. & Sacks, F. M. Dietary unsaturated fat increases HDL metabolic pathways involving apoE favorable to reverse cholesterol transport. JCI Insight. 4(7), e124620 (2019).
Pang, S., Li, J., Zhang, Y. & Chen, J. Meta-analysis of the relationship between the APOE gene and the onset of Parkinson’s disease dementia. Parkinson’s Disease https://doi.org/10.1155/2018/9497147 (2018).
Phillips, M. C. Apolipoprotein E isoforms and lipoprotein metabolism. IUBMB Life 66(9), 616–623 (2014).
Uddin, M. S. et al. APOE and Alzheimer’s disease: Evidence mounts that targeting APOE4 may combat Alzheimer’s pathogenesis. Mol. Neurobiol. 56(4), 2450–2465 (2019).
Knouff, C. et al. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J. Clin. Investig. 103(11), 1579–1586 (1999).
Liu, S., Liu, J., Weng, R., Gu, X. & Zhong, Z. Apolipoprotein E gene polymorphism and the risk of cardiovascular disease and type 2 diabetes. BMC Cardiovasc. Disord. 19(1), 1–6 (2019).
Wang, Q. Q., Davis, P. B., Gurney, M. E. & Xu, R. COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimer’s Dement. 17, 1297–1306. https://doi.org/10.1002/alz.12296 (2021).
Goldstein, M. R., Poland, G. A. & Graeber, C. W. Does apolipoprotein E genotype predict COVID-19 severity?. QJM Int. J. Med. 113(8), 529–530 (2020).
Xiong, N., Schiller, M. R., Li, J., Chen, X. & Lin, Z. Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again?. Alzheimer’s Res. Therapy. https://doi.org/10.1186/s13195-021-00858-9 (2021).
Wu, W., Wang, A. & Liu, M. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223), 497–506 (2020).
Tsai, P.-H. et al. Clinical manifestation and disease progression in COVID-19 infection. J. Chin. Med. Assoc. 84(1), 3–8 (2021).
Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet. 395(10229), 1054–1062 (2020).
Chan, J. F. W. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 395(10223), 514–523 (2020).
Onder, G., Rezza, G. & Brusaferro, S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 323(18), 1775–1776 (2020).
Ellinghaus, D. et al. The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis. MedRxiv Preprint Server Health Sci. https://doi.org/10.1101/2020.05.31.20114991v1.full (2020).
Wang, F. et al. Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility. Cell Discovery 6(1), 1–16 (2020).
Velavan, T. P. et al. Host genetic factors determining COVID-19 susceptibility and severity. EBioMedicine 72, 103629 (2021).
Kuo, C.-L. et al. ApoE e4e4 genotype and mortality with COVID-19 in UK Biobank. J. Gerontol. Ser. A 75(9), 1801–1803 (2020).
Gkouskou, K. et al. COVID-19 enters the expanding network of apolipoprotein E4-related pathologies. Redox Biol. 41, 101938 (2021).
Kosmicki, J. A. et al. Genetic association analysis of SARS-CoV-2 infection in 455,838 UK Biobank participants. MedRxiv Preprint Server Health Sci. https://doi.org/10.1101/2020.10.28.20221804v1 (2020).
Wang, C. et al. ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response. Cell Stem Cell 28(2), 331–42 e5 (2021).
Wang, H., Yuan, Z., Pavel, M. A. & Hansen, S. B. Cholesterol and COVID19 lethality in elderly. BioRxiv. https://doi.org/10.1101/2020.05.09.086249v1.full (2020).
Figueroa, D. M., Gordon, E. M., Yao, X. & Levine, S. J. Apolipoproteins as context-dependent regulators of lung inflammation. In Mechanisms and Manifestations of Obesity in Lung Disease (eds Johnston, R. A. & Suratt, B. T.) 301–326 (Academic Press, Berlin, 2019). https://doi.org/10.1016/B978-0-12-813553-2.00013-0.
del Ser, T. et al. Residence, clinical features, and genetic risk factors associated with symptoms of COVID-19 in a cohort of older people in Madrid. Gerontology 67(3), 281–289 (2021).
Espinosa-Salinas, et al. Potential protective effect against SARS-CoV-2 infection by APOE rs7412 polymorphism. Sci. Rep. 12(1), 7247 (2022).
Mwer, S., Dykes, D. & Polesky, H. J. N. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 16(3), 1215 (1988).
Yang, Y. G. et al. Apolipoprotein E genotyping by multiplex tetra-primer amplification refractory mutation system PCR in single reaction tube. J. Biotechnol. 131(2), 106–110 (2007).